Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients
Our findings indicate a high frequency of MYD88 L265P mutations in our study population and not associated with prognostic markers or the outcome of the disease.
Authors
- Shaimaa El‐Ashwah (ORCID: https://orcid.org/0000-0003-2210-1534)
- Layla M. Saleh (ORCID: https://orcid.org/0000-0002-4753-7257)
- Sameh Shamaa (ORCID: https://orcid.org/0000-0001-7807-9677)
- Ahmed Hanbal
- Ahmed E. Eladl
Institutions
- Mansoura University (EG)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1186/s43046-024-00237-z
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42